conivaptan has been researched along with Acquired Nephrogenic Diabetes Insipidus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arthus, MF; Bernier, V; Bichet, DG; Bouvier, M; Brouard, R; Debrand, N; Laperrière, A; Lonergan, M; Morello, JP; Salahpour, A; Zarruk, A | 1 |
Greenberg, A; Verbalis, JG | 1 |
1 review(s) available for conivaptan and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
Vasopressin receptor antagonists.
Topics: Antidiuretic Hormone Receptor Antagonists; Azepines; Benzamides; Benzazepines; Clinical Trials as Topic; Diabetes Insipidus, Nephrogenic; Fibrosis; Heart Failure; Humans; Hyponatremia; Osmolar Concentration; Polycystic Kidney Diseases; Pyrroles; Receptors, Vasopressin; Sodium; Tolvaptan; United States; United States Food and Drug Administration; Vasopressins | 2006 |
1 other study(ies) available for conivaptan and Acquired Nephrogenic Diabetes Insipidus
Article | Year |
---|---|
Pharmacologic chaperones as a potential treatment for X-linked nephrogenic diabetes insipidus.
Topics: Adult; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cells, Cultured; Chromosomes, Human, X; Diabetes Insipidus, Nephrogenic; Genetic Linkage; Humans; Indoles; Male; Mutation; Pyrrolidines; Receptors, Vasopressin | 2006 |